At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 22 enrolled
Drug / intervention
Oxygen +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Normobaric Oxygen (NBO) Therapy in Acute Migraine
In Brief
A Phase 2 clinical trial evaluating Oxygen and Room air for Migraine. Completed, enrolled 22 participants across 1 site.
Detailed Summary
This is a pilot study investigating the therapeutic potential of breathing 100% oxygen in acute migraine headache.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 2012
Enrollment StartJul 2012
Primary CompletionSep 2015
TodayJul 2026
First PostedMar 2, 2012
Enrollment StartJul 1, 2012
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 14.3 years ago
Interventions
Oxygenbiological
Oxygen is inhaled for 30 minutes during migraine attack
Room airbiological
Placebo